Regulus Therapeutics Inc. Business Finance Contracts & Agreements

Amendment to Loan and Security Agreement, dated June 19, 2023, by and between the Registrant and Oxford Finance, LLC (Filed With SEC on August 8, 2023)

Description of Common Stock (Filed With SEC on March 23, 2023)

Form of Common Stock Certificate of the Registrant (Filed With SEC on August 11, 2022)

Regulus Therapeutics Inc. 2022 Employee Stock Purchase Plan (Filed With SEC on August 11, 2022)

Description of Common Stock (Filed With SEC on March 11, 2022)

Tenth Amendment to Loan and Security Agreement, dated August 25, 2020, by and among the Registrant and Oxford Finance, LLC (Filed With SEC on March 11, 2022)

Eleventh Amendment to Loan and Security Agreement, dated December 31, 2021, by and between the Company and Oxford Finance LLC (Filed With SEC on January 5, 2022)

Second Amendment to Loan and Security Agreement, dated March 6, 2018, by and between the Registrant and Oxford Finance LLC (Filed With SEC on March 9, 2021)

Form of Common Stock Purchase Warrant (Filed With SEC on December 4, 2020)

Securities Purchase Agreement, dated December 1, 2020, by and among the Company and the Purchasers (Filed With SEC on December 4, 2020)

Tenth Amendment to Loan and Security Agreement, dated August 25, 2020, by and between the Registrant and Oxford Finance, LLC (Filed With SEC on November 5, 2020)

Ninth Amendment to Loan and Security Agreement, dated May 1, 2020, by and between the Registrant and Oxford Finance, LLC (Filed With SEC on May 14, 2020)

Description of Common Stock (Filed With SEC on March 12, 2020)

Seventh Amendment to Loan and Security Agreement, dated April 9, 2019, by and between the Registrant and Oxford Finance LLC (Filed With SEC on May 10, 2019)

Form of Common Stock Purchase Warrant (Filed With SEC on May 9, 2019)

Securities Purchase Agreement, dated May 3, 2019, by and among the Company and the Purchasers (Filed With SEC on May 9, 2019)

Eighth Amendment to Loan and Security Agreement, dated May 3, 2019, by and between the Company and Oxford Finance LLC (Filed With SEC on May 9, 2019)

Fourth Amendment to Loan and Security Agreement, dated November 5, 2018, by and between the Registrant and Oxford Finance LLC (Filed With SEC on March 18, 2019)

Sixth Amendment to Loan and Security Agreement, dated March 7, 2019, by and between the Registrant and Oxford Finance LLC (Filed With SEC on March 18, 2019)

Fifth Amendment to Loan and Security Agreement, dated January 31, 2019, by and between the Registrant and Oxford Finance LLC (Filed With SEC on February 1, 2019)

Common Stock Sales Agreement, dated December 12, 2018, by and between Regulus Therapeutics Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on December 12, 2018)

Form of common stock certificate of the Registrant (Filed With SEC on November 9, 2018)

First Amendment to Loan and Security Agreement, dated October 4, 2017, by and between the Registrant and Oxford Finance LLC (Filed With SEC on March 8, 2018)

Second Amendment to Loan and Security Agreement, dated March 6, 2018, by and between the Registrant and Oxford Finance LLC (Filed With SEC on March 8, 2018)

RELEASE AND WAIVER OF CLAIMS (Filed With SEC on August 2, 2017)

44,000,000Shares REGULUS THERAPEUTICS INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on July 20, 2017)

LOAN AND SECURITY AGREEMENT (Filed With SEC on August 3, 2016)

5,294,118 Shares REGULUS THERAPEUTICS INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on October 29, 2014)

[ ] Shares REGULUS THERAPEUTICS INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on June 26, 2013)

REGULUS THERAPEUTICS INC. INVESTOR RIGHTS AGREEMENT REGULUS THERAPEUTICS INC. INVESTOR RIGHTS AGREEMENT (Filed With SEC on October 11, 2012)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on October 11, 2012)

REGULUS THERAPEUTICS INC. 2012 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS:SEPTEMBER 7, 2012 APPROVED BY THESTOCKHOLDERS: SEPTEMBER 7, 2012 (Filed With SEC on September 7, 2012)

[ ] Shares REGULUS THERAPEUTICS INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on August 17, 2012)

REGULUS THERAPEUTICS INC. 2012 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS:AUGUST 8, 2012 APPROVED BY THESTOCKHOLDERS: , 2012 (Filed With SEC on August 17, 2012)

REGULUS THERAPEUTICS INC. FOUNDING INVESTOR RIGHTS AGREEMENT REGULUS THERAPEUTICS INC. FOUNDING INVESTOR RIGHTS AGREEMENT (Filed With SEC on August 17, 2012)

AMENDMENT NUMBER ONE TO THE FOUNDING INVESTOR RIGHTS AGREEMENT (Filed With SEC on August 17, 2012)

AMENDMENT NUMBER TWO TO THE FOUNDING INVESTOR RIGHTS AGREEMENT (Filed With SEC on August 17, 2012)

REGULUS THERAPEUTICS INC. INVESTOR RIGHTS AGREEMENT REGULUS THERAPEUTICS INC. INVESTOR RIGHTS AGREEMENT (Filed With SEC on August 17, 2012)